Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s, N0, M0 rectal cancer

Pericay, C; Serra-Aracil, X; Ocaña-Rojas, J; Mora-López, L; Dotor, E; Casalots, A; Pisa, A; Saigí, E.
Clin. transl. oncol. (Print) ; 18(7): 666-671, jul. 2016. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-153490

Documentos relacionados

  1. [Prerequisites for Safe Implementation of Transanal Total Mesorectal Excision].
  2. Oncological outcomes and stoma-free survival following TaTME, a prospective cohort study.
  3. Comment on: Norwegian moratorium on transanal total mesorectal excision.
  4. Author response to: Comments on: Norwegian moratorium on transanal total mesorectal excision.
  5. Quality of life after transanal total mesorectal excision - our experience.
  6. Transanal endoscopic surgery with a 3D printed device.
  7. Transanal total mesorectal excision for low and middle rectal cancer: time for audit?
  8. Giant pedunculated rectal polyps in transanal endoscopic surgery: The larger, the more inverted - a video vignette.
  9. Quality indicators for operative reporting in transanal endoscopic surgery.
  10. A Strict Patient Selection Protocol Could Be the Key to Success for Transanal Minimally Invasive Surgery (TAMIS).